Showing 19,761 - 19,780 results of 102,262 for search '(( e fold decrease ) OR ( 5 ((point decrease) OR (((a decrease) OR (mean decrease)))) ))', query time: 1.53s Refine Results
  1. 19761
  2. 19762
  3. 19763
  4. 19764
  5. 19765

    Tumor Cells Switch to Mitochondrial Oxidative Phosphorylation under Radiation via mTOR-Mediated Hexokinase II Inhibition - A Warburg-Reversing Effect by Chung-Ling Lu (711442)

    Published 2015
    “…Three tumor cell lines (breast cancer MCF-7, colon cancer HCT116 and glioblastoma U87) showed a quick relocation of mTOR to mitochondria after irradiation with a single dose 5 Gy, which was companied with decreased lactate production, increased mitochondrial ATP generation and oxygen consumption. …”
  6. 19766
  7. 19767

    Conformational characterization of a novel anti-HER2 candidate antibody by Leina Moro Pérez (6686177)

    Published 2019
    “…In this work, the conformational features of a novel monoclonal antibody (called 5G4) were evaluated by means of circular dichroism spectroscopy and fluorescence. …”
  8. 19768
  9. 19769

    <em>In Vitro</em> and <em>Ex Vivo</em> Analysis of <em>CHRNA3</em> and <em>CHRNA5</em> Haplotype Expression by Glenn A. Doyle (209929)

    Published 2011
    “…For <em>in vitro</em> analyses, promoter haplotypes were sub-cloned into a luciferase reporter vector. When assessed in BE(2)-C cells, luciferase expression was equivalent among <em>CHRNA3</em> haplotypes, but the combination of deletion at rs3841324 and variation at rs503464 decreased <em>CHRNA5</em> promoter-derived luciferase activity, possibly due to loss of an SP-1 and other site(s). …”
  10. 19770
  11. 19771
  12. 19772

    Effects of a clinical medication review focused on personal goals, quality of life, and health problems in older persons with polypharmacy: A randomised controlled trial (DREAMeR-s... by Sanne Verdoorn (6680822)

    Published 2019
    “…Over 6 months, in the intervention group, HR-QoL measured with EQ-VAS increased by 3.4 points (95% confidence interval [CI] 0.94 to 5.8; <i>p</i> = 0.006), and the number of health problems with impact on daily life decreased by 12% (difference at 6 months −0.34; 95% CI −0.62 to −0.044; <i>p</i> = 0.024) as compared with the control group. …”
  13. 19773

    Overexpression of tau inhibited whole-cell currents through Kv channels. by Xiantao Li (683919)

    Published 2015
    “…<p>(A) The outward Kv currents were evoked by stepped up to +60 mV for 500 ms at a holding potential of -80 mV in N2A cells. …”
  14. 19774
  15. 19775
  16. 19776
  17. 19777

    Changes in ELF5, FOXA1 and ER binding to the genome are reflected in gene expression. by Catherine L. Piggin (8212272)

    Published 2020
    “…Panel <b>B</b>, as for panel A but showing genes for which FOXA1 or ER binding was increased or decreased by induction of ELF5. …”
  18. 19778

    PRMT5 isoforms during zebrafish developmental stages by Zain Zakaria (20354028)

    Published 2024
    “…Q503E3). Mobility of Prmt5 at 72 hpf indicated a lower apparent molecular weight compared to the 24 hpf zebrafish Prmt5 variant 1. …”
  19. 19779

    ELF5 transcriptional effects measured by RNA-seq. by Catherine L. Piggin (8212272)

    Published 2020
    “…<p>Panel <b>A</b>, GO ontologies enriched in the RNA-seq data set by induction of ELF5, font size relative to enrichment score. …”
  20. 19780

    The MITF-SOX10 regulated long non-coding RNA DIRC3 is a melanoma tumour suppressor by Elizabeth A. Coe (8195508)

    Published 2019
    “…<i>DIRC3</i> is a nuclear lncRNA that activates expression of its neighbouring <i>IGFBP5</i> tumour suppressor through modulating chromatin structure and suppressing SOX10 binding to putative regulatory elements within the <i>DIRC3</i> locus. …”